Papers

7

Total Citations

61

H-Index

5

About

G. Assenmacher is a urologic surgeon and researcher whose work centers on advancing robotic-assisted surgery for urologic cancers, with a particular focus on radical cystectomy for bladder cancer and prostatectomy for prostate cancer. His major contributions lie in systematically evaluating and improving the outcomes of robot-assisted radical cystectomy (RARC) with intracorporeal urinary diversion (ICUD). He has led key studies that define the morbidity of this complex procedure using the novel Comprehensive Complication Index, providing a more nuanced understanding of patient risk than traditional grading systems. His work also includes a multi-institutional analysis of over 1,000 patients examining the impact of perioperative blood transfusions on oncologic outcomes, as well as a cost-analysis comparing RARC across European countries. Notably, Assenmacher co-authored the first clinical validation of the ERUS training curriculum for RARC, a critical step for standardizing surgical education. His research, which has accumulated over 60 citations, consistently addresses practical challenges in robotic surgery, from quality-of-life assessments after prostatectomy to the safety of continuing acetylsalicylic acid during cystectomy. He is also exploring novel focal therapies, such as targeted microwave ablation for prostate cancer, demonstrating a commitment to both refining established techniques and pioneering new, less invasive treatments.

Research Focus

Key Achievements

5
H-Index
7
Papers
61
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Cost-analysis of robot-assisted radical cystectomy in Europe: A cross-country comparison
15 citations · 2022
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 52
🏛 Institutions: Cliniques du Sud Luxembourg, Université Libre de Bruxelles

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago